Katleen De Preter - Concepedia

Author

Katleen De Preter

Also Known As

DE PRETER K, De Preter, Katleen, Deborah A. Tweddle, Frank Speleman, Givani Dewyn, K De Preter, K DePreter, K de Preter, K. De Preter, K. De Preter

491

Publications

28.3K

Citations

H-Index

114

Concepts

All Affiliations

Ghent University Hospital Ghent University Cancer Research Institute Ghent Essen University Hospital Heidelberg University

About

Katleen De Preter is an author at Ghent University Hospital specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	44	3.8K
2	Engineering	5	5	995
3	Natural Sciences	4	4	124
4	Public Health	3	3	109
5	Health Sciences	1	1	64

Katleen De Preter

106

Publications

27.1K

Citations

H-Index

Page 1

	Year	Citations
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Jo Vandesompele, Katleen De Preter, Filip Pattyn, Genome biology	2002	19.7K
Benchmarking of cell type deconvolution pipelines for transcriptomics data Francisco Avila Cobos, José Alquicira-Hernández, Joseph E. Powell, Nature Communications EngineeringTranscriptomics TechnologyGenomicsHigh Throughput SequencingSingle Cell Sequencing	2020	473
Mutational dynamics between primary and relapse neuroblastomas Alexander Schramm, Johannes Köster, Yassen Assenov, Nature Genetics Tumor HeterogeneityMutational DynamicsPathologyNeuroblastsMedicine	2015	314
Evaluation of qPCR curve analysis methods for reliable biomarker discovery: Bias, resolution, precision, and implications Jan M. Ruijter, Michael W. Pfaffl, Sheng Zhao, Methods Biomarker (Medicine)EngineeringMedicineBiomarker TargetProteomics	2012	265
Measurable impact of RNA quality on gene expression results from quantitative PCR Joëlle Vermeulen, Katleen De Preter, Steve Lefever, Nucleic Acids Research EngineeringGeneticsPathologyTranscriptomics TechnologyQuantitative Pcr	2011	200
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study Joëlle Vermeulen, Katleen De Preter, Arlene Naranjo, The Lancet Oncology Neuro-oncologyPediatric Brain TumorsPediatric NeurosurgeryRetrospective Siopen/cog/gpoh StudyPediatrics	2009	194
Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma Presha Rajbhandari, Gonzalo López, Claudia Capdevila, Cancer Discovery GeneticsPathologyDisease Gene IdentificationMycnamp NeuroblastomasCancer Biology	2018	187
Asthma inflammatory phenotypes show differential microRNA expression in sputum Tania Maes, Francisco Avila Cobos, Florence Schleich, Journal of Allergy and Clinical Immunology AsthmaInflammationInflammatory Lung DiseaseLung InflammationImmunology	2016	186
Quantification of MYCN, DDX1, and NAG Gene Copy Number in Neuroblastoma Using a Real-Time Quantitative PCR Assay Katleen De Preter, Frank Speleman, Valérie Combaret, Modern Pathology Tumor BiologyTumor InnervationGliomaMedicinePathology	2002	181
Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma Jo Vandesompele, Michael Baudis, Katleen De Preter, Journal of Clinical Oncology	2005	180

Page 1